Literature DB >> 21701919

A QM/MM study of the binding of RAPTA ligands to cathepsin B.

Antonella Ciancetta1, Samuel Genheden, Ulf Ryde.   

Abstract

We have carried out quantum mechanical (QM) and QM/MM (combined QM and molecular mechanics) calculations, as well as molecular dynamics (MD) simulations to study the binding of a series of six RAPTA (Ru(II)-arene-1,3,5-triaza-7-phosphatricyclo-[3.3.1.1] decane) complexes with different arene substituents to cathepsin B. The recently developed QM/MM-PBSA approach (QM/MM combined with Poisson-Boltzmann solvent-accessible surface area solvation) has been used to estimate binding affinities. The QM calculations reproduce the antitumour activities of the complexes with a correlation coefficient (r (2)) of 0.35-0.86 after a conformational search. The QM/MM-PBSA method gave a better correlation (r (2) = 0.59) when the protein was fixed to the crystal structure, but more reasonable ligand structures and absolute binding energies were obtained if the protein was allowed to relax, indicating that the ligands are strained when the protein is kept fixed. In addition, the best correlation (r (2) = 0.80) was obtained when only the QM energies were used, which suggests that the MM and continuum solvation energies are not accurate enough to predict the binding of a charged metal complex to a charged protein. Taking into account the protein flexibility by means of MD simulations slightly improves the correlation (r (2) = 0.91), but the absolute energies are still too large and the results are sensitive to the details in the calculations, illustrating that it is hard to obtain stable predictions when full flexible protein is included in the calculations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701919     DOI: 10.1007/s10822-011-9448-7

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  43 in total

1.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

2.  Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT.

Authors:  Angela Casini; Fabio Edafe; Mikael Erlandsson; Luca Gonsalvi; Antonella Ciancetta; Nazzareno Re; Andrea Ienco; Luigi Messori; Maurizio Peruzzini; Paul J Dyson
Journal:  Dalton Trans       Date:  2010-05-14       Impact factor: 4.390

3.  On the Convergence of QM/MM Energies.

Authors:  LiHong Hu; Pär Söderhjelm; Ulf Ryde
Journal:  J Chem Theory Comput       Date:  2011-02-07       Impact factor: 6.006

4.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

5.  Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.

Authors:  Angela Casini; Chiara Gabbiani; Elena Michelucci; Giuseppe Pieraccini; Gloriano Moneti; Paul J Dyson; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-03-14       Impact factor: 3.358

Review 6.  Metal-based antitumour drugs in the post genomic era.

Authors:  Paul J Dyson; Gianni Sava
Journal:  Dalton Trans       Date:  2006-03-28       Impact factor: 4.390

Review 7.  From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

Authors:  Christian G Hartinger; Stefanie Zorbas-Seifried; Michael A Jakupec; Bernd Kynast; Haralabos Zorbas; Bernhard K Keppler
Journal:  J Inorg Biochem       Date:  2006-02-28       Impact factor: 4.155

8.  Reactivity of an antimetastatic organometallic ruthenium compound with metallothionein-2: relevance to the mechanism of action.

Authors:  Angela Casini; Andrei Karotki; Chiara Gabbiani; Francesco Rugi; Milan Vašák; Luigi Messori; Paul J Dyson
Journal:  Metallomics       Date:  2009-08-11       Impact factor: 4.526

9.  Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.

Authors:  Angela Casini; Chiara Gabbiani; Francesca Sorrentino; Maria Pia Rigobello; Alberto Bindoli; Tilmann J Geldbach; Alessandro Marrone; Nazzareno Re; Christian G Hartinger; Paul J Dyson; Luigi Messori
Journal:  J Med Chem       Date:  2008-10-04       Impact factor: 7.446

10.  Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound.

Authors:  Alberta Bergamo; Alessia Masi; Paul J Dyson; Gianni Sava
Journal:  Int J Oncol       Date:  2008-12       Impact factor: 5.650

View more
  8 in total

1.  Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.

Authors:  Mingli Xiang; Yuchun Lin; Gu He; Lijuan Chen; Mingli Yang; Shengyong Yang; Yirong Mo
Journal:  J Mol Model       Date:  2012-06-27       Impact factor: 1.810

2.  Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes.

Authors:  Leonor Côrte-Real; Filipa Mendes; Joana Coimbra; Tânia S Morais; Ana Isabel Tomaz; Andreia Valente; M Helena Garcia; Isabel Santos; Manuel Bicho; Fernanda Marques
Journal:  J Biol Inorg Chem       Date:  2014-02-23       Impact factor: 3.358

3.  Effects of bidentate coordination on the molecular properties rapta-C based complex using theoretical approach.

Authors:  Adebayo A Adeniyi; Peter A Ajibade
Journal:  J Mol Model       Date:  2012-11-28       Impact factor: 1.810

Review 4.  Induced fit docking, and the use of QM/MM methods in docking.

Authors:  Mengang Xu; Markus A Lill
Journal:  Drug Discov Today Technol       Date:  2013-09

Review 5.  The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities.

Authors:  Samuel Genheden; Ulf Ryde
Journal:  Expert Opin Drug Discov       Date:  2015-04-02       Impact factor: 6.098

6.  Superior Performance of the SQM/COSMO Scoring Functions in Native Pose Recognition of Diverse Protein-Ligand Complexes in Cognate Docking.

Authors:  Haresh Ajani; Adam Pecina; Saltuk M Eyrilmez; Jindřich Fanfrlík; Susanta Haldar; Jan Řezáč; Pavel Hobza; Martin Lepšík
Journal:  ACS Omega       Date:  2017-07-27

Review 7.  Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies.

Authors:  Brigitta Elsässer; Peter Goettig
Journal:  Int J Mol Sci       Date:  2021-03-22       Impact factor: 5.923

8.  Comparing the suitability of autodock, gold and glide for the docking and predicting the possible targets of Ru(II)-based complexes as anticancer agents.

Authors:  Adebayo A Adeniyi; Peter A Ajibade
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.